New treatment to reverse drug resistance in some cancers
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas.
Jun 28, 2018
0
85
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas.
Jun 28, 2018
0
85
Oral squamous cell carcinomas (OSCCs) are the most common head and neck cancers, but are often diagnosed late.
Jun 26, 2018
0
6
(HealthDay)—If you could protect yourself from cancer, you'd do it, right? Yet most Americans still aren't taking the easiest step to prevent the most commonly diagnosed type—skin cancer, which will affect one in five ...
Jun 15, 2018
0
0
Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University ...
Jun 4, 2018
0
4
High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer. In a novel study in The American Journal of Pathology investigators found that CKAP4 levels were significantly ...
May 8, 2018
0
6
(HealthDay)—A proactive speech and language pathology (SLP) program is beneficial for patients with head and neck squamous cell carcinoma (HNSCC), according to a study published online April 19 in JAMA Otolaryngology-Head ...
Apr 26, 2018
0
1
(HealthDay)—Most active smokers with head and neck squamous cell carcinoma (HNSCC) have made one or more quit attempts, according to a study published online April 12 in JAMA Otolaryngology-Head & Neck Surgery.
Apr 20, 2018
0
5
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers). A new Journal ...
Apr 19, 2018
0
2
Researchers from UCLA and Long Beach Memorial Medical Center have found that two targeted therapies could be more effective if used in combination to treat squamous cell carcinomas of the lung. The two drugs, MLN128 and CB-839, ...
Apr 12, 2018
0
5
A single letter DNA mutation is a big determinant of whether patients with advanced oral cancer respond to treatments. Researchers from the National Cancer Centre Singapore (NCCS) and A*STAR who uncovered the mechanisms behind ...
Mar 23, 2018
0
3